Expert Review of Hematology

SJR Rank #8,225H-index: 61SJR: 0.702Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • HematologyQ2

Areas: Medicine

Most published research topics

Lymphoma Diagnosis and TreatmentAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchHemoglobinopathies and Related DisordersPlatelet Disorders and TreatmentsMultiple Myeloma Research and TreatmentsHemophilia Treatment and ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsBlood groups and transfusion

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs080160240320

Documents per Year

202220250306090120

Detailed Information

ISSN

1747-4086, 1747-4094

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.54

References per Document

54.23

Coverage

2008-2026

Scope

Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.

Metrics from SCImago Journal Rank 2025. View on SCImago